NCT07719660

Brief Summary

The goal of this clinical trial is to compare the accuracy, clinical applicability, and usability of different wearable blood pressure monitoring methods integrated in wearable devices, such as smartwatches, in hospitalized patients. The study evaluates novel photoplethysmography (PPG)-based and wrist-oscillometric blood pressure measurement methods against established clinical reference methods (upper-arm cuff measurements on the general ward and invasive arterial blood pressure monitoring (A-line) in the intensive care unit). The main questions the study aims to answer are:

  • Can novel blood pressure monitoring methods suitable for integration into wearable devices achieve clinically acceptable agreement with established reference measurements?
  • How does the performance of calibration-dependent wearable devices change over time following calibration?
  • How does the performance of the investigated methods compare with each other?
  • How do the investigated methods perform for patients with different pre-existing conditions ? To answer these questions, participants will undergo:
  • blood pressure measurements using different wearable devices based on PPG and wrist oscillometry
  • standardized reference blood pressure measurements using an upper-arm cuff (general ward) or an existing invasive arterial line (intensive care unit)
  • repeated measurements over three consecutive days on the general ward to assess calibration stability and measurement reproducibility,

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
18mo left

Started Jul 2026

Geographic Reach
2 countries

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jul 2026Dec 2027

First Submitted

Initial submission to the registry

July 18, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

July 20, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 22, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 23, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 18, 2026

Last Update Submit

July 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Agreement of wearable blood pressure measurement methods with clinical reference measurements

    The mean difference and standard deviation of the differences in systolic and diastolic blood pressure, expressed in mmHg, between each investigated wearable blood pressure measurement method and the corresponding reference method.

    General ward: At each measurement session on study days 1, 2, and 3. ICU: At measurement session on study day 1, approx. 2 hours after device calibration

Study Arms (2)

Cohort at general ward

Cohort at ICU

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hospitalized adult patients aged 21 to 85 years who are treated on participating general wards or intensive care units at the hospital and are able to provide written informed consent.

You may qualify if:

  • Blood pressure measurements can be performed on at least one arm, for example no amputation, dialysis shunt, or obstructive dressing
  • Ability to understand the study information and provide written informed consent
  • For participants in the intensive care unit: an arterial line placed for clinical reasons

You may not qualify if:

  • Wrist circumference exceeds the size range of the investigated wearable devices
  • Physical or medical conditions preventing placement of the wearable devices, including relevant skin lesions, wounds, severe edema, or patient restraint
  • Inability to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital Dresden

Dresden, Saxony, 01307, Germany

Location

Careggi University Hospital

Florence, FI, 50134, Italy

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 18, 2026

First Posted

July 22, 2026

Study Start

July 20, 2026

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 23, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

We plan to provide the anonymized IPD after publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
after finishing the study, data will be stored locally for at least 10 years
Access Criteria
contact the investigators via mail

Locations